Details For Selected Brain Tumor Treatment

Sponsored By

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors

		Keywords:		Topotecan

		Phase:		Phase 1/2

		Treatment ID#s:		VT1082 NCT00452959

		Age Group:		Adult And Pediatric

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed This trial enrolls patients with a recurrent malignant Brain Tumor(Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, ect.) situated in one cerebral hemisphere

		Last Updated:		08/20/2007

		Tumor Types:		Anaplastic Astrocytoma Any Malignant Brain Tumor Germ Cell Tumors Glioblastoma Multiforme Medulloblastoma Mixed Glioma Oligodendroglioma High Grade Recurrent Malignant Pediatric Brain Tumors


		Comments:		Patients who have already received Topotecan are excluded

		Treatment Type:		Surgery Chemotherapy.

		Contact:		Columbia University Medical Center Jeffrey Bruce, MD Neurosurgeon 710 WEST 168TH STREET 4th Floor NEW YORK CITY, NY 10032 Phone:212 305-7346 Fax: 212 305-2026 Click here to send an email Website: www.columbianeurosurgery.org

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By